Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy.

about

Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy.

Item

http://www.wikidata.org/entity/Q49882490

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of Demographic Features ...... f Hypertrophic Cardiomyopathy.

@en

Impact of Demographic Features ...... f Hypertrophic Cardiomyopathy.

@nl

type

Item

label

Impact of Demographic Features ...... f Hypertrophic Cardiomyopathy.

@en

Impact of Demographic Features ...... f Hypertrophic Cardiomyopathy.

@nl

prefLabel

Impact of Demographic Features ...... f Hypertrophic Cardiomyopathy.

@en

Impact of Demographic Features ...... f Hypertrophic Cardiomyopathy.

@nl

P1476

Impact of Demographic Features ...... f Hypertrophic Cardiomyopathy.

@en

P2093

Emma Magavern

http://www.w3.org/2001/XMLSchema#string

Euan Ashley

http://www.w3.org/2001/XMLSchema#string

Gherardo Finocchiaro

http://www.w3.org/2001/XMLSchema#string

Gianfranco Sinagra

http://www.w3.org/2001/XMLSchema#string

Iacopo Olivotto

http://www.w3.org/2001/XMLSchema#string

Michael Papadakis

http://www.w3.org/2001/XMLSchema#string

P2860

A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia

Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas

Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training

Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy.

Risk associated with pregnancy in hypertrophic cardiomyopathy.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy

Soy diet worsens heart disease in mice.

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death.

P31

scholarly article

review article

P356

10.1161/JAHA.117.007161

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sanjay Sharma

Maria Teresa Tome Esteban

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29237589

http://www.w3.org/2001/XMLSchema#string

P932

5779031

http://www.w3.org/2001/XMLSchema#string